Windlas Biotech Ltd posts consolidated PAT of Rs. 11.44 crores in Q4FY23

Windlas Biotech Ltd has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 143.047 crores during the period ended March 31, 2023 as compared to Rs. 121.866 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 11.444 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 9.188 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 5.37 for the period ended March 31, 2023 as compared to Rs. 4.23 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹143.047 crs	₹121.866 crs	17.38%
Net Profit	₹11.444 crs	₹9.188 crs	24.55%
EPS	₹5.37	₹4.23	26.95%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.143.047 crores during the period ended March 31, 2023 as compared to Rs.125.136 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.11.444 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.14.788 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.5.37 for the period ended March 31, 2023 as compared to Rs.6.97 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹143.047 crs	₹125.136 crs	14.31%
Net Profit	₹11.444 crs	₹14.788 crs	-22.61%
EPS	₹5.37	₹6.97	-22.96%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.523.048 crores during the Financial Year ended March 31, 2023 as compared to Rs.472.636 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.42.626 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.38.089 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.19.70 for the Financial Year ended March 31, 2023 as compared to Rs.18.58 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹523.048 crs	₹472.636 crs	10.67%
Net Profit	₹42.626 crs	₹38.089 crs	11.91%
EPS	₹19.70	₹18.58	6.03%

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 254.80 as compared to the previous close of Rs. 255.10. The total number of shares traded during the day was 3668 in over 202 trades.

The stock hit an intraday high of Rs. 259.55 and intraday low of 252.80. The net turnover during the day was Rs. 939869.00.

Source : Equity Bulls

Keywords

WindlasBiotech Q4FY23 FY2023 ResultUpdate